Evidence map›Paper›PMID 41153708›Full record

ArticleBiomedicines2025

Bolus MPTP Injection in Aged Mice to Mimic Parkinson Disease: Effects of Low-Dose Antioxidant Treatment with Fullerene (C

Tatyana Strekalova, Alisa Burova, Anna Gorlova, Kirill Chaprov, Anastasia Khizeva, Joana E Coelho, Evgeniy Svirin, Polina Novikova, Lia Ohanyan, Johannes J M P de Munter and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Beneficial Effects of Putative Hydrogen Sulfide (HMolecules (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tatyana StrekalovaDivision of Molecular Psychiatry, Center of Mental Health, University Hospital Würzburg, 97080 Würzburg, Germany.ORCID 0000-0001-9937-5600
Alisa BurovaDepartment of Basic and Biomedical Sciences, Université Paris Cité, 75006 Paris, France.
Anna GorlovaResearch and Education Resource Center, Peoples Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
Kirill ChaprovInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 119071 Chernogolovka, Russia.ORCID 0000-0002-0258-1879
Anastasia KhizevaInstitute of Physiologically Active Compounds at Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, 119071 Chernogolovka, Russia.
Joana E CoelhoFaculdade de Medicina de Lisboa, Gulbenkian Institute for Molecular Medicine, 1649-028 Lisbon, Portugal.
Evgeniy SvirinNeuroplast B.V., 6229 EV Maastricht, The Netherlands.
Polina NovikovaDepartment of Normal Physiology, Sechenov University, 119991 Moscow, Russia.
Lia OhanyanLaboratory of Toxinology, Orbely Institute of Physiology of NAS RA, Yerevan 0028, Armenia.
Johannes J M P de MunterNeuroplast B.V., 6229 EV Maastricht, The Netherlands.ORCID 0000-0001-7583-1464
Naira AyvazyanLaboratory of Toxinology, Orbely Institute of Physiology of NAS RA, Yerevan 0028, Armenia.ORCID 0000-0002-7588-2277
Luisa V LopesFaculdade de Medicina de Lisboa, Gulbenkian Institute for Molecular Medicine, 1649-028 Lisbon, Portugal.
Aleksei UmriukhinDepartment of Normal Physiology, Sechenov University, 119991 Moscow, Russia.
Gohar ArajyanPharmacology and Pathohistology laboratory, Scientific Technological Center of Organic and Pharmaceutical Chemistry, The National Academy of Sciences of Armenia, Yerevan 0019, Armenia.ORCID 0009-0002-7638-4162
Harry W M SteinbuschDepartment of Cellular and Translational Neuroscience, Faculty Health, Medicine and Life Sciences, Maastricht University, 6229 HA Maastricht, The Netherlands.ORCID 0000-0002-7667-0604

Funding

HORIZON-RISE PhytoApp 101007642 EU frameworkMinistry of Research and Education of RF FFSG-2024-0020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)agingantioxidantsbehaviordopaminefullerenefullerenolmicenitric oxide synthaseParkinson’s disease (PD)sex bias

Identifiers

PMID41153708
PMCPMC12561033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.